Inclusion criteria:
Body Temperature > 37.5ºC and highest point <39ºC within 24hours of enrollment,
Within 12 hours of screening, three or more of the following main symptoms: Nasal Congestion, Rhinorrhea, Sore and/or scratchy throat, sneezing, headache, muscle or body aches, or malaise.
The subject has signed the informed consent form.
Exclusion criteria:
Other Respiratory diseases or acute and chronic nasal diseases or abnormal nasal mucosal function after nasal surgery or nasopharyngeal radiotherapy
Severe primary health conditions associated with cardiovascular, cerebrovascular, pulmonary, hepatic, renal, endocrine and hematological diseases, hematopoietic system and mental illness or serious diseases affecting their survival, such as cancer or AIDS
With severe cardiopulmonary dysfunction, cardiopulmonary insufficiency
Subjects, who were treated with other Chinese and western drugs (including drugs for common cold, antiviral, antibiotics, and similar traditional Chinese medicine) and antipyretic and analgesic drugs within 6 hours before enrollment.
Allergic individuals and those who are known to be allergic to experimental drugs.
Pregnant women, and lactating women
Subject, who has participated in the past 1 month in another clinical study.
Subjects who are not suitable for the clinical trial based on investigators’ judgment.
Subjects who consume alcohol.